Go Pro
→ The ultimate IPO unicorn (From Weiss Ratings) (Ad)tc pixel Free MPT Stock Alerts

Medical Properties Trust (MPT) Earnings Date, Estimates & Call Transcripts

Medical Properties Trust logo
$4.09 -0.61 (-12.98%)
As of 01:22 PM Eastern
Compare

Medical Properties Trust Earnings Summary

Medical Properties Trust issued Q2 2026 earnings on August 10, 2026, reporting an EPS of $0.15, which hit analysts' consensus estimates of $0.15. Quarterly revenue rose 7.9% year-over-year to $259.28 million. With a trailing EPS of -$0.21, Medical Properties Trust's earnings are expected to grow 9.52% next year, from $0.63 to $0.69 per share.

Latest Q2
Earnings Date
Aug. 10Confirmed
Consensus EPS
(Aug. 10)
$0.15
Actual EPS
(Aug. 10)
$0.15
Actual Revenue
(Aug. 10)
$259.28M

Q2 2026 Earnings Resources

Powered by Quartr
Get Medical Properties Trust Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medical Properties Trust and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Medical Properties Trust Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.63 EPS
Next Year EPS Consensus Estimate
$0.69 EPS

Medical Properties Trust Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026$0.15$0.15--$0.01-$259.28M
4/30/2026Q1 2026$0.15$0.05 -$0.10$0.05$252.59M$252.07M

Medical Properties Trust Earnings - Frequently Asked Questions

Medical Properties Trust has confirmed that its next quarterly earnings data will be published on Monday, August 10th, 2026. Learn more on MPT's earnings history.

In the previous quarter, Medical Properties Trust (NYSE:MPT) reported $0.15 earnings per share (EPS) to hit the analysts' consensus estimate of $0.15. Learn more on analysts' earnings estimate vs. MPT's actual earnings.

Medical Properties Trust (NYSE:MPT) has a recorded annual revenue of $972.02 million.

Medical Properties Trust (NYSE:MPT) has a recorded net income of -$277.05 million. MPT has generated -$0.21 earnings per share over the last four quarters.

Medical Properties Trust's earnings are expected to grow from $0.63 per share to $0.69 per share in the next year, which is a 9.52% increase.

Related Companies
Earnings Tools

Earnings data for NYSE:MPT is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for P...
The Tomorrow Investor | Sponsoredtc pixel
SpaceX is NOT the #1 IPO of 2026
A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew f...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
If your money lives inside one bank, pay close attention. On December 1st, 2025, a Congressional committee pub...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
This Junior Silver Explorer Is Closing In on Its Biggest Catalyst
A past-producing Nevada silver project holds a historical 36 million ounce silver-equivalent resource, plus mo...
Wall Street Logic | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel